Overview
Indegene is an Indian healthcare-focused technology and solutions company that provides commercialisation, clinical, regulatory and medical services to pharmaceutical, biotechnology and medical device firms. The company combines domain expertise in life sciences with digital technology, analytics and operations to support drug development and commercialisation processes.
| Industry | Healthcare services, life sciences technology |
|---|---|
| Headquarters | Bengaluru, Karnataka, India |
| Country | India |
| Sector served | Pharmaceutical, biotechnology and medical device companies |
| Listing | Listed on the BSE and NSE following its initial public offering in 2024 |
Background
Indegene operates at the intersection of healthcare, life sciences and technology. Its services span medical communications, regulatory affairs, pharmacovigilance, clinical operations, omnichannel marketing for pharmaceutical brands, and analytics. The company works with global pharmaceutical clients and supports activities related to the launch and lifecycle management of drugs and therapies.
Headquartered in Bengaluru, the company has built delivery centres in India alongside offices in North America, Europe and Asia to serve clients across major pharmaceutical markets. Its workforce includes professionals with backgrounds in medicine, pharmacy, life sciences, data science and software engineering.
History
Indegene was founded in the late 1990s in Bengaluru, initially focusing on medical content and communications for the pharmaceutical industry. Over the following two decades it expanded its offerings to include enterprise commercial operations, clinical and regulatory services, and digital platforms for life sciences clients.
The company received private equity investment from firms including CA Healthcare Investments, supporting its expansion into international markets. In 2024, Indegene completed an initial public offering on Indian stock exchanges, transitioning from a privately held firm to a publicly listed company.
Services
- Enterprise commercial solutions: omnichannel marketing, sales enablement and customer engagement support for pharmaceutical brands.
- Medical and regulatory services: medical writing, medical affairs support, regulatory operations and compliance.
- Clinical solutions: support for clinical trial operations, biostatistics and data management.
- Pharmacovigilance: safety case processing, signal management and risk management activities.
- Technology and analytics: proprietary platforms and analytics tools tailored to life sciences workflows.
Significance
Indegene is among the larger Indian companies dedicated specifically to outsourced services for the global pharmaceutical industry, a segment distinct from broader IT services and contract research organisations. Its public listing in 2024 was viewed as a notable event in the Indian healthcare services sector, reflecting investor interest in life sciences operations and digital transformation businesses based in India.
Related topics
- Pharmaceutical industry in India
- Contract research organisation
- Information technology in India
- Bengaluru
- List of companies of India
References
- Wikidata entity: Q22031522
- Filings and disclosures associated with Indegene's listing on Indian stock exchanges.